This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of molecules targeting various therapeutic areas, including central nervous system disorders and inflammatory diseases. Its trifluoromethyl group enhances the compound's metabolic stability and binding affinity to biological targets, making it valuable in medicinal chemistry. Additionally, it is explored in the development of enzyme inhibitors and receptor modulators, contributing to the advancement of treatments for complex medical conditions.